Discontinued — last reported Q4 '22
Current Assets
Raw materials
West Pharmaceutical Services Raw materials increased by 5.7% to $172.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $162.90M to $172.50M. Over 5 years (FY 2020 to FY 2025), Raw materials shows an upward trend with a 4.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ4 2022
Parent metricInventories
How to read this metric
High levels may signal proactive supply chain hedging against shortages, while low levels could indicate lean inventory management or potential supply risks.
Detailed definition
The cost of basic components and supplies held for use in the manufacturing of finished products. This inventory serves...
Peer comparison
Standard across manufacturing sectors; levels vary based on supply chain strategy and lead times.
Metric ID:
inv_raw_materialsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $130.20M | $140.40M | $153.80M | $167.40M | $177.30M | $179.00M | $170.70M | $181.00M | $185.30M | $180.20M | $172.30M | $174.00M | $173.70M | $170.30M | $166.90M | $162.90M | $173.70M | $183.00M | $163.20M | $172.50M |
| QoQ Change | — | +7.8% | +9.5% | +8.8% | +5.9% | +1.0% | -4.6% | +6.0% | +2.4% | -2.8% | -4.4% | +1.0% | -0.2% | -2.0% | -2.0% | -2.4% | +6.6% | +5.4% | -10.8% | +5.7% |
| YoY Change | — | — | — | — | +36.2% | +27.5% | +11.0% | +8.1% | +4.5% | +0.7% | +0.9% | -3.9% | -6.3% | -5.5% | -3.1% | -6.4% | +0.0% | +7.5% | -2.2% | +5.9% |
| % of Inventories | 37.7% | 39.7% | 40.6% | 40.2% | 43.1% | 43.3% | 41.2% | 40.5% | 41.2% | 41.7% | 39.6% | 40.5% | 41.4% | 42.4% | 44.3% | 41.9% | 41.2% | 41.8% | 36.8% | 38.1% |
| Share Change | — | +2.0pp | +1.0pp | -0.5pp | +2.9pp | +0.3pp | -2.2pp | -0.7pp | +0.7pp | +0.5pp | -2.1pp | +0.8pp | +1.0pp | +1.0pp | +1.8pp | -2.4pp | -0.7pp | +0.5pp | -5.0pp | +1.3pp |
Range$130.20M – $185.30M
CAGR+6.1%
Avg YoY Growth+4.7%
Median YoY Growth+0.8%
Raw materials at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's raw materials?
- West Pharmaceutical Services (WST) reported raw materials of $172.50M in Q1 2026.
- How has West Pharmaceutical Services's raw materials changed year-over-year?
- West Pharmaceutical Services's raw materials increased by 5.9% year-over-year, from $162.90M to $172.50M.
- What is the long-term trend for West Pharmaceutical Services's raw materials?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's raw materials has grown at a 4.1% compound annual growth rate (CAGR), from $133.50M to $163.20M.
- What does raw materials mean?
- The value of basic materials and supplies waiting to be used in production.